Stock Alert: Tenable Holdings Hits New High Following Q2 Results, Outlook

Shares of cyber security solutions provider Tenable Holdings, Inc. (TENB) are up more than 14% Wednesday morning following beter-than-expected second-quarter results. The company also provided third-quarter as well as full-year outlook, exceeding analysts' view.

The stock touched a new high of $35.01 this morning.

Second-quarter earnings per share of $0.04, beat the average estimate of analysts polled by Thomson Reuters of $0.05 loss per share and compared to a loss per share of $0.10 in the second quarter of 2019.

Revenue for the quarter was $107.2 million, up 26% year-over-year.

For the third-quarter, Tenable expects revenue in the range of $108.0 million to $110.0 million and adjusted earnings per share in the range of $0.02 to $0.03. Analysts expect loss of $0.05 per share on revenue of $108.74 million for the quarter.

For the full-year ending December 31, 2020, the company sees revenue in the range of $428.0 million to $433.0 million and adjusted earnings per share in the range of $0.00 to $0.03. The consensus estimate for earnings is $0.25 loss per share on revenue of $427.48 million.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Biotech Stocks by Subscribing to RTT Biotech Investor.
Editors Pick
The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023. Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said. The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings. Saliva-based COVID-19 testing is rolled out as a pilot for public schools in New York City. The new two-month pilot program is being implemented in about 50 New York City public schools and utilizes Fluidigm Technology to offer RT-PCR COVID-19 testing. New York City public schools have instituted mandatory random weekly testing in all reopened school buildings to ensure safer in-person learning.
Follow RTT